Search
Clinical Trial
Randomized Phase 2 Trial of APL-2 with Pembrolizumab vs. APL-2 with Pembrolizumab and Bevacizumab vs. Bevacizumab alone in Patients with Recurrent Ovarian Cancer and Persistent Malignant Effusion
… Ovarian Cancer and Persistent Malignant Effusion II Zsiros, Emese This phase II trial studies the effect of APL-2 …
Clinical Trial
NRG-GY036: A Phase III Trial of One vs. Two Years of Maintenance Olaparib, With or Without Bevacizumab, in Patients With BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum Based…
… Following Response to First Line Platinum Based… III Zsiros, Emese This phase III trial compares the effect of …
News
Roswell Park Team Demonstrates Safe Approach for Dramatically Reducing Use of Opioids Following Surgery
… patients undergoing surgery, gynecologic oncologist Emese Zsiros, MD, PhD, FACOG , proposed a new pain-management … or recovery at all,” says study Senior Author Dr. Zsiros, Associate Professor of Oncology in the Department of … patients undergoing surgery, gynecologic oncologist Emese Zsiros, MD, PhD, FACOG , proposed a new pain-management …
Tumor Immunology & Immunotherapy Program Members
… Chair, Department of Immunology View the Abrams Lab Emese Zsiros, MD, PhD, FACOG Associate Professor of Oncology …
Research
Roswell Park-University of Chicago Ovarian Cancer SPORE Faculty and Staff
… Core Roswell Park Comprehensive Cancer Center Emese Zsiros, MD, PhD, FACOG Co-Leader (Clinical), Individual … Core Roswell Park Comprehensive Cancer Center Emese Zsiros, MD, PhD, FACOG Co-Leader (Clinical), Individual …
Clinical Trial
A Phase 1a/1b Study of 27T51, an anti-MUC16 CAR T cell drug product administered alone or in combination for participants with recurrent or refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( 27T51-01)
… primary peritoneal, or fallopian tube cancer ( 27T51-01) I Zsiros, Emese This study is researching an experimental CAR T …
Blog Post
Team Science Award to advance research on acute myeloid leukemia
… “Evaluating T-cells for Ovarian Cancer,” led by Emese Zsiros, MD, PhD, FACOG , Assistant Professor of Oncology in … Oncology and Center for Immunotherapy Of her project, Dr. Zsiros said, “Our project brings hope and innovation. With … “Evaluating T-cells for Ovarian Cancer,” led by Emese Zsiros, MD, PhD, FACOG , Assistant Professor of Oncology in …
Clinical Trial
Life on the Go 3: A Randomized Controlled Trial of Automated, Personalized Physical Activity Intervention Using Wearable Devices to Improve Immune Function and Clinical Outcomes in Ovarian and Endometrial Cancer Patients
… Outcomes in Ovarian and Endometrial Cancer Patients N/A Zsiros, Emese This clinical trial compares the effect of an …
News
Donations to Roswell Park, 11 Day Power Play Launch New Cancer Research Studies
… “Novel ncRNA fusions in soft tissue sarcomas.” Emese Zsiros, MD, PhD , Department of Gynecology, received $98,848 … “Novel ncRNA fusions in soft tissue sarcomas.” Emese Zsiros, MD, PhD , Department of Gynecology, received $98,848 …
Blog Post
Women in Science: Clinical research nurses
… Share Mother's Passion for Nursing Women in Science: Emese Zsiros MD, PhD Meet the Team Cancer Research & News … When …